Nobel Biocare is a leading global provider of innovative implant-based dental restorations. Based in Zürich, Switzerland, Nobel Biocare is renowned for its pioneering contributions to the field of implant dentistry and its commitment to improving patient care through advanced dental solutions.
History
Nobel Biocare was founded in 1981, building on the groundbreaking research of Professor Per-Ingvar Brånemark, who discovered the principles of osseointegration, which became the foundation for modern dental implants. The company quickly became a trailblazer in the dental industry, commercializing the first dental implants and continuing to innovate with new products and technologies.
Position in the Dental Industry
Nobel Biocare is positioned as a leader in the dental implant industry. Its comprehensive portfolio includes dental implants, individualized prosthetics, CAD/CAM systems, digital solutions for treatment planning, guided surgery, and biomaterials. The company’s solutions are designed to enhance patient outcomes, streamline workflows for dental professionals, and ensure long-term success.
Reputation
Nobel Biocare has earned a stellar reputation for its commitment to quality, innovation, and clinical excellence. The company collaborates with dental professionals worldwide, providing them with the tools, training, and support needed to deliver optimal patient care. Nobel Biocare’s products are backed by extensive scientific research and clinical evidence, reinforcing its position as a trusted leader in the dental community.
Size and Global Presence
Nobel Biocare operates globally, with a presence in over 80 countries. The company’s headquarters are located in Zürich, Switzerland, and it has production sites in Europe, the United States, and Japan. Nobel Biocare’s extensive distribution network ensures that its products and services are accessible to dental professionals and patients around the world.
Number of Employees
As of 2023, Nobel Biocare employs approximately 3,000 people worldwide. The company’s dedicated and skilled workforce is instrumental in driving its innovation and maintaining its high standards of quality and service. Nobel Biocare fosters a collaborative and dynamic work environment, encouraging continuous learning and professional development.
Annual Sales
Nobel Biocare has consistently achieved strong financial performance, reflecting its leadership in the dental implant industry and the growing demand for its solutions. In 2022, the company reported annual sales of approximately USD 1 billion. This robust revenue growth underscores Nobel Biocare’s strategic vision, operational excellence, and commitment to advancing dental care.
Research and Development
Nobel Biocare invests heavily in research and development (R&D) to drive innovation and improve patient outcomes. The company collaborates with leading academic institutions, research organizations, and dental professionals to develop new products and technologies. Nobel Biocare’s R&D efforts focus on enhancing the reliability, aesthetics, and functionality of dental implants and restorative solutions.
Sustainability and Corporate Responsibility
Nobel Biocare is committed to sustainability and corporate social responsibility. The company implements environmentally sustainable practices throughout its operations and actively supports initiatives that promote oral health and access to dental care. Nobel Biocare’s commitment to ethical business practices and social responsibility is integral to its mission of improving patient care and contributing to the well-being of communities worldwide.
Nobel Biocare’s dedication to quality, innovation, and clinical excellence has made it a global leader in the dental implant industry. With a rich history rooted in scientific discovery, a strong global presence, and a commitment to research and development, Nobel Biocare continues to set new standards in dental care, enhancing the lives of patients and supporting dental professionals worldwide.